Trevi Therapeutics Inc’s recently made public that its President & CEO GOOD JENNIFER L unloaded Company’s shares for reported $12784.0 on Sep 06 ’24. In the deal valued at $3.03 per share,4,219 shares were sold. As a result of this transaction, GOOD JENNIFER L now holds 213,313 shares worth roughly $0.75 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, GOOD JENNIFER L sold 1,840 shares, generating $5,587 in total proceeds. Upon selling the shares at $3.04, the President & CEO now owns 213,313 shares.
Before that, GOOD JENNIFER L sold 40,277 shares. Trevi Therapeutics Inc shares valued at $125,310 were divested by the President & CEO at a price of $3.11 per share. As a result of the transaction, GOOD JENNIFER L now holds 213,313 shares, worth roughly $0.75 million.
A number of analysts have revised their coverage, including Raymond James’s analysts, who began to cover the stock in late August with a ‘”an Outperform”‘ rating. H.C. Wainwright began covering TRVI with “Buy” recommendation on August 30, 2024. Rodman & Renshaw started covering the stock on June 13, 2024. It rated TRVI as “a Buy”.
Price Performance Review of TRVI
On Monday, Trevi Therapeutics Inc [NASDAQ:TRVI] saw its stock jump 4.15% to $3.51. Over the last five days, the stock has gained 12.50%. Trevi Therapeutics Inc shares have risen nearly 161.94% since the year began. Nevertheless, the stocks have risen 65.57% over the past one year. While a 52-week high of $4.00 was reached on 03/21/24, a 52-week low of $0.97 was recorded on 01/22/24. SMA at 50 days reached $2.93, while 200 days put it at $2.48.
Levels Of Support And Resistance For TRVI Stock
The 24-hour chart illustrates a support level at 3.37, which if violated will result in even more drops to 3.23. On the upside, there is a resistance level at 3.67. A further resistance level may holdings at 3.82. The Relative Strength Index (RSI) on the 14-day chart is 67.45, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.28, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 20.00%. Stochastics %K at 77.66% indicates the stock is a holding.
How much short interest is there in Trevi Therapeutics Inc?
A steep rise in short interest was recorded in Trevi Therapeutics Inc stocks on 2024-08-30, growing by 0.26 million shares to a total of 1.55 million shares. Yahoo Finance data shows the prior-month short interest on 2024-07-31 was 1.29 million shares. There was a rise of 16.78%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on April 12, 2023 when B. Riley Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $6 price target.
